Ashman Phenomenon: An Often Unrecognized Entity in Daily Clinical Practice by Lakušić Lakušić et al.
Acta Clin Croat,  Vol. 48,  No. 3,  2009 99
Acta Clin Croat 2010; 49:99-100 Letter to the Editor
ASHMAN PHENOMENON: AN OFTEN UNRECOGNIZED 
ENTITY IN DAILY CLINICAL PRACTICE
Nenad Lakušić1, Darija Mahović2and Valentina Slivnjak1
1Department of Cardiology, Hospital for Medical Rehabilitation, Krapinske Toplice; 2University Department of 
Neurology, Zagreb University Hospital Center, Zagreb, Croatia
Correspondence to Nenad Lakušić, MD, PhD, Department of 
Cardiology, Hospital for Medical Rehabilitation, Gajeva 2, HR-
49217 Krapinske Toplice, Croatia 
E-mail: nenad.lakusic@post.htnet.hr
Dear Editor,
We decided to reply with this letter regarding 
the entity that is often unrecognized in daily clinical 
practice. 
Ashman phenomenon is an aberrant ventricular 
conduction most frequently seen during atrial fi bril-
lation. Th is phenomenon is an intraventricular con-
duction abnormality caused by a change in the heart 
rate. Ashman beat is typically seen when a relatively 
long cycle is followed by a relatively short cycle1. Th e 
beat with a short cycle often has right bundle-branch 
block (RBBB) morphology (Fig. 1a). Th is phenom-
enon may cause diagnostic confusion with premature 
ventricular complexes (PVCs) (Fig. 1b), and a series 
of consecutive aberrantly conducted supraventricular 
impulses may be mistaken for ventricular tachycardia 
(Fig. 1c). 
Th e pathophysiology of Ashman phenomenon de-
pends on the relative refractory period of the conduc-
tion tissues and the heart rate. Th e duration of the 
refractory period of the heart muscle is proportional 
to the R-R interval of the preceding cycle. A longer 
cycle will prolong the ensuing refractory period, and if 
a shorter cycle follows the beat terminating the cycle 
is likely to be conducted with aberrancy. Th e refrac-
tory period of the right bundle-branch is longer than 
the left one and it will still be in the refractory pe-
riod when supraventricular impulse reaches the His-
Purkinje system resulting in a complex with RBBB2,3. 
Ashman phenomenon is principally diagnosed by a 
12-lead surface electrocardiogram (ECG). Rarely, in 
diffi  cult cases, invasive electrophysiological studies 
will be required to establish the source of an arrhyth-
mia whether supraventricular or ventricular4.
For daily use, useful criteria to establish the diag-
nosis of Ashman phenomenon are those described by 
Fisch5: 1) relatively long cycle immediately preceding 
the cycle terminated by the aberrant QRS complex; 2) 
RBBB-form aberrancy with normal orientation of the 
initial QRS vector, a series of wide QRS supraven-
tricular beats is possible; 3) irregular coupling of aber-
rant QRS complexes; and 4) lack of fully compensa-
tory pause. 
Clinically, Ashman phenomenon by itself is asymp-
tomatic and does not require any specifi c treatment. 
Finally, although Ashman phenomenon has been 
known for more than sixty years now1, it still often 
stays unrecognized, or misdiagnosed as PVCs. Un-
derstanding Ashman phenomenon is useful and nec-
essary in daily clinical practice because, for example, in 
24-hour Holter ECG records we can fi nd even several 
thousand wide QRS complexes caused by Ashman 
phenomenon. It usually occurs with atrial fi brillation, 
and atrial fi brillation is the most common sustained 
cardiac rhythm disturbance, increasing in prevalence 
with age6. Furthermore, not only the cardiologists, 
but often physicians of diff erent profi les such as neu-
rologists, anesthesiologists, general practitioners, etc. 
see it and treat it. 
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In conclusion, it is important to notice that in a pa-
tient with atrial fi brillation and wide QRS complexes 
with RBBB morphology, Ashman phenomenon must 
be considered to avoid further unnecessary diagnostic 
and, more important, therapeutic procedures.
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Fig. 1. Holter ECG records in Ashman phenomenon: (A) 
atrial fi brillation with aberrant conduction – Ashman phe-
nomenon (4th beat); (B) the same patient – note the ECG 
morphology diff erence between ventricular ectopic beat (4th 
beat) and aberrant conduction – Ashman phenomenon (8th 
and 9th beats); (C) aberrant conduction run – Ashman phe-
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